| Description | CNNM2 Human Pre-designed siRNA Set A contains three designed siRNAs for CNNM2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control. Components CNNM2 siRNA-1: 5 nmol (HPLC) CNNM2 siRNA-2: 5 nmol (HPLC) CNNM2 siRNA-3: 5 nmol (HPLC) siRNA Negative Control:CNNM2 Human Pre-designed siRNA Set A contains three designed siRNAs for CNNM2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control. Components CNNM2 siRNA-1: 5 nmol (HPLC) CNNM2 siRNA-2: 5 nmol (HPLC) CNNM2 siRNA-3: 5 nmol (HPLC) siRNA Negative Control: 5 nmol (HPLC) FAM-labeled siRNA Negative Control: 5 nmol (HPLC) GAPDH siRNA Positive Control:5 nmol (HPLC)... Read More | The Leuconostoc GPDH exhibits dual coenzyme specificity, namely NAD and NADP (Olive and Levy, Biochem., 6, 730 730, 1967). When assayed under conditions that are optimal for the particular coenzyme, the ratio of observed catalytic activity is NAD/NADP = 1.8 | Inquire | Purity>95% (SDS-PAGE) Endotoxin level<1.0 EU/µgFunctionInhibits the synthesis of a number of cytokines, including IFN-gamma, IL-2, IL-3, TNF and GM-CSF produced by activated macrophages and by helper T-cells | Purity>97% by SDS-PAGE and HPLC analyses.Additional sequence informationN-terminal Glycine.FunctionChemotactic for monocytes and T-lymphocytes. Binds to CXCR3.Post-translationalCXCL10(1-73) is produced by proteolytic cleavage after secretion from keratinocytes |